Catagen, a spin-out of Queen’s University Belfast, has secured a deal worth £700,000 ($1.17m) which will see the Northern Ireland-based firm expand into the US.
The company is developing catalyst testing equipment. The deal will see its largest testing product, the Maxcat, used by automotive firm Mahle at its US facility of its subsidiary Mahle Powertrain.
Andrew Woods, chief executive of Catagen, said: “The partnership between Mahle Powertrain LLC and Catagen will help further accelerate introduction into the US market, as well as the adoption of this breakthrough technology.”
Hugh Blaxill, General Manager, Mahle Powertrain, added: “We are very pleased to be able to work with Catagen to be the first to bring this unique catalyst aging solution to the U.S. auto industry. The Maxcat’s testing and aging solutions deliver significant reductions in operating costs with an increase in testing flexibility and agility.”
